E-LIB Suche - Ergebnisse für: Roeten, Margot

1

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR..:

Roeten, Margot ; van Dijk, Suzanne ; van Meerloo, Johan...
HemaSphere. 7 (2023) S3 - p. e81299a0 , 2023

2

(Immuno)proteasomes as therapeutic target in acute leukemia:

Cloos, Jacqueline ; Roeten, Margot SF ; Franke, Niels E...
Cancer and Metastasis Reviews. 36 (2017) 4 - p. 599-615 , 2017

Link: https://doi.org/10.1007/..

3

1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivat..:

Carbone, Daniela ; Pecoraro, Camilla ; Panzeca, Giovanna...
Marine Drugs. 21 (2023) 7 - p. 412 , 2023

Link: https://doi.org/10.3390/..

4

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomi..:

Roeten, Margot S.F. ; van Meerloo, Johan ; Kwidama, Zinia J....
Cells. 10 (2021) 3 - p. 665 , 2021

Link: https://doi.org/10.3390/..

5

Positioning of proteasome inhibitors in therapy of solid ma..:

Roeten, Margot S. F. ; Cloos, Jacqueline ; Jansen, Gerrit
Cancer Chemotherapy and Pharmacology. 81 (2017) 2 - p. 227-243 , 2017

Link: https://doi.org/10.1007/..

6

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR..:

Roeten, Margot ; van Dijk, Suzanne ; van Meerloo, Johan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428354/. , 2023

Link: http://www.ncbi.nlm.nih...

7

P329: HIGH IMMUNOPROTEASOME ACTIVITY AS NOVEL INDICATOR FOR..:

Margot Roeten ; Suzanne van Dijk ; Johan van Meerloo...
http://journals.lww.com/10.1097/01.HS9.0000968228.81299.a0. , 2023

Link: https://doi.org/10.1097/..

8

1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivat..:

Carbone, Daniela ; Pecoraro, Camilla ; Panzeca, Giovanna...
info:eu-repo/semantics/altIdentifier/pmid/37504943. , 2023

Link: https://hdl.handle.net/1..

9

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomi..:

Roeten, Margot S.F ; van Meerloo, Johan ; Kwidama, Zinia J...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002577/. , 2021

Link: http://www.ncbi.nlm.nih...

10

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomi..:

Roeten, Margot S. F ; van Meerloo, Johan ; Kwidama, Zinia J...
Roeten , M S F , van Meerloo , J , Kwidama , Z J , ter Huizen , G , Segerink , W H , Zweegman , S , Kaspers , G J L , Jansen , G & Cloos , J 2021 , ' Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomib against Bortezomib-Resistant Leukemia Cells and Primary Acute Leukemia Cells ' , Cells , vol. 10 , no. 3 , 665 , pp. 1-15 . https://doi.org/10.3390/cells10030665. , 2021

Link: https://research.vumc.nl..

11

Positioning of proteasome inhibitors in therapy of solid ma..:

Roeten, Margot S.F ; Cloos, Jacqueline ; Jansen, Gerrit
Roeten , M S F , Cloos , J & Jansen , G 2018 , ' Positioning of proteasome inhibitors in therapy of solid malignancies ' , Cancer Chemotherapy and Pharmacology , vol. 81 , no. 2 , pp. 227-243 . https://doi.org/10.1007/s00280-017-3489-0. , 2018

Link: https://research.vumc.nl..

12

1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivat..:

Daniela Carbone ; Camilla Pecoraro ; Giovanna Panzeca...
https://www.mdpi.com/1660-3397/21/7/412. , 2023

Link: https://doi.org/10.3390/..

13

1,3,4-Oxadiazole and 1,3,4-Thiadiazole Nortopsentin Derivat..:

Daniela Carbone ; Camilla Pecoraro ; Giovanna Panzeca...
Marine Pharmacology. , 2023

Link: https://doi.org/10.3390/..

14

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomi..:

Margot S.F. Roeten ; Johan van Meerloo ; Zinia J. Kwidama...
https://www.mdpi.com/2073-4409/10/3/665. , 2021

Link: https://doi.org/10.3390/..

15

Pre-Clinical Evaluation of the Proteasome Inhibitor Ixazomi..:

Margot S.F. Roeten ; Johan van Meerloo ; Zinia J. Kwidama...
https://dx.doi.org/10.3390/cells10030665. , 2021

Link: https://doi.org/10.3390/..